Mohammad Alashqar | Digital Transformation | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Mohammad Alashqar
The Ohio State University, United States

Mohammad Alashqar
Affiliation The Ohio State University
Country United States
Google Scholar ID 2z79wywAAAAJ
Documents 7
Subject Area Digital Transformation
Event Business Global Awards
ORCID 0009-0004-7635-8567

Mohammad Alashqar is affiliated with The Ohio State University and is associated with research spanning digital transformation and healthcare-related evidence synthesis. The publication record supplied for this profile includes systematic reviews, meta-analyses, pharmacotherapy research, health technology assessment, and cost-effectiveness analysis published in international scholarly journals. These works illustrate an interdisciplinary research orientation connecting digital health, clinical evidence, therapeutics, and health-economic evaluation. [1] [2] [3] [4]

Abstract

This academic recognition profile presents the research activities and publication record associated with Mohammad Alashqar, The Ohio State University, with a stated subject area of Digital Transformation. The supplied publications cover evidence-based evaluation of digital health interventions, systematic reviews and meta-analyses in heart failure, emerging therapies for hemophilia, and health-economic assessment of treatment strategies. One 2026 publication examines digital health interventions incorporating educational components for patients with heart failure, while other publications address pharmacological and economic dimensions of contemporary clinical care. [1] [2] [3] [4]

Keywords

Digital Transformation; Digital Health; Healthcare Research; Systematic Review; Meta-Analysis; Heart Failure; Hemophilia; Fitusiran; Pharmacotherapy; Health Economics; Cost-Effectiveness; Clinical Evidence; Evidence-Based Medicine.

Introduction

Digital transformation in healthcare encompasses the application of digital technologies, data-driven methods, and digitally enabled services to improve the delivery, evaluation, and management of healthcare. Academic research in this area increasingly intersects with clinical evidence synthesis, patient education, treatment evaluation, and health-economic analysis. Within this broader context, the supplied publication record associated with Mohammad Alashqar includes research addressing digital health interventions as well as systematic assessment of therapeutic approaches. [1]

The publications identified for this profile were published in 2026 in journals including Healthcare, Annals of Pharmacotherapy, Cardiology in Review, and Value in Health. Their subject matter ranges from patient-facing digital health interventions to pharmacological innovation and economic evaluation. Together, these studies demonstrate an emphasis on synthesizing available evidence to inform clinical and healthcare decision-making. [1] [2] [3] [4]

Research Profile

The supplied profile identifies Mohammad Alashqar with The Ohio State University in the United States and lists Digital Transformation as the principal subject area. The provided academic record contains seven documents. Citation and h-index values were not supplied in the source information and are therefore not assigned numerical values in this article.

Research Contributions

Digital health and patient education. The systematic review and meta-analysis titled Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure examines digital health interventions that incorporate educational components for patients with heart failure. Published in Healthcare in August 2026, the study contributes to evidence concerning the clinical role of digitally enabled patient education and intervention strategies. [1]

Therapeutic innovation in hemophilia. The publication Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors addresses fitusiran as an antithrombin-targeting therapeutic approach for hemophilia A and B. Published in Annals of Pharmacotherapy in July 2026, the work contributes to the scholarly discussion surrounding emerging treatment strategies in hemophilia. [2]

Publications

  1. Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Healthcare. 2026;14(16):2460.[1]
  2. Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors. Annals of Pharmacotherapy. 2026. [2]
  3. Efficacy and Safety of Combination Pharmacotherapies With Standard Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis. Cardiology in Review. 2026.[3]
  4. EE490 COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS. Value in Health. 2026.[4]

Research Impact

The supplied publications address questions with practical relevance to healthcare decision-making. The digital health study contributes evidence concerning interventions that combine technology with educational components for people living with heart failure. The fitusiran review considers an emerging therapeutic strategy in hemophilia, while the acute heart failure meta-analysis evaluates pharmacological combinations in a clinically significant setting. The health-economic study adds an economic perspective to prophylactic treatment selection. [1] [2] [3] [4]

Award Suitability

The supplied research record provides a reasonable academic basis for consideration under an Innovative Research Award category associated with Business Global Awards. Its relevance arises from the combination of digital health research, evidence synthesis, emerging therapeutics, clinical effectiveness assessment, and health-economic evaluation. The digital health publication is particularly aligned with the stated subject area of Digital Transformation because it evaluates digitally enabled interventions with an educational component for patients with heart failure. [1]

Conclusion

Mohammad Alashqar’s supplied publication record reflects multidisciplinary research at the intersection of digital transformation, healthcare evidence, pharmacotherapy, cardiovascular medicine, hematology, and health economics. The 2026 publications demonstrate engagement with systematic evidence synthesis and the evaluation of contemporary healthcare interventions. The combination of digital health research and clinically oriented evidence assessment provides a relevant foundation for academic recognition under an Innovative Research Award framework, subject to independent verification and the applicable award criteria. [1] [2] [3] [4]

References

  1. MDPI. (2026). Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Healthcare, 14(16), 2460.
    https://doi.org/10.3390/healthcare14162460
  2. SAGE Publishing. (2026). Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors. Annals of Pharmacotherapy.
    https://doi.org/10.1177/10600280251403512
  3. Wolters Kluwer. (2026). Efficacy and Safety of Combination Pharmacotherapies With Standard Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis. Cardiology in Review.
    https://doi.org/10.1097/crd.0000000000001337
  4. Elsevier. (2026). EE490 COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS. Value in Health.
    https://doi.org/10.1016/j.jval.2026.03.783
  5. ORCID. (n.d.). Mohammad Alashqar — ORCID Profile.
    https://orcid.org/0009-0004-7635-8567
  6. Research profile supplied for Mohammad Alashqar, The Ohio State University. Profile identifier: 2z79wywAAAAJ. Citation and h-index values were not supplied in the source data for this article.
    https://scholar.google.com/citations?hl=en&user=2z79wywAAAAJ

Xiaoyan Pan | Digital Transformation Strategy | Best Researcher Award

Published on by Business Global Awards

Dr. Xiaoyan Pan – Digital Transformation Strategy – Best Researcher Award

Alignment with Award Category

Dr. Pan’s research aligns well with the Best Researcher Award or Excellence in Innovation category. Her focus on strategic innovation in the context of digital transformation reflects an advanced understanding of emerging trends and their applications in management. Her contributions to teaching reform, municipal and provincial research projects, and her ability to integrate theoretical insights with practical applications further validate her candidacy

Taizhou University | China

🎓Early Academic Pursuits 

Education and Training

Dr. Pan Xiaoyan, a distinguished scholar in the field of management, laid the foundation for her academic excellence with a robust educational journey. Her passion for management studies led her to specialize in strategic management, innovation, and entrepreneurship. Dr. Pan’s academic rigor culminated in her dissertation, “A Study of the Relationship Between Strategic Orientation and New Product Development Performance in the Context of Digital Transformation: The Mediating Role of Digital Capabilities and Dual Innovation.” This dissertation not only reflects her profound understanding of the complexities of digital transformation but also sets the stage for her future contributions to the field.

 

💼Professional Endeavors 

Academic Positions

Currently, Dr. Pan Xiaoyan serves as a faculty member at the School of Economics and Management, Taizhou University. She has established herself as an expert in her discipline by teaching pivotal courses such as Management Information Systems. Her professional qualifications, including the National Informatization Engineer Certification in Project Management (Advanced Faculty Level), Accounting Qualification, and Vocational Core Competency Teaching Qualification, underline her dedication to academic and professional excellence. Dr. Pan has also contributed significantly to teaching reform, leading a university-level project aimed at improving educational methodologies. Her involvement in municipal and provincial research projects further highlights her active engagement in addressing regional and national challenges in the field of management.

 

📚Contributions and Research Focus on Digital Transformation Strategy

Dr. Pan Xiaoyan’s research focuses on strategic management, innovation, and entrepreneurship, particularly in the context of digital transformation. Her groundbreaking work explores how digital capabilities and strategic orientation influence new product development performance. She has published extensively in international, national, and provincial-level journals, with eight notable papers to her credit. Key contributions include: Strategic Orientation, Digital Capabilities, and New Product Development in Emerging Market Firms: The Moderating Role of Corporate Social Responsibility (Sustainability, 2021) – This study examines how corporate social responsibility moderates the relationship between strategic orientation and digital capabilities in emerging markets. The Rise of Corporate Digital Transformation and Government Regulatory Innovation (East Asian Journal of Business Economics, 2021) – This paper highlights the interplay between corporate innovation and government regulations in the digital era. Digital Supply Chain: Green Synergy Effects of Intelligent Technology and Dynamic Capabilities—An Empirical Study Based on 200 Manufacturing Enterprises (Supply Chain Management, 2023) – This empirical study emphasizes how intelligent technology fosters green synergy in supply chain management.

 

🏆Accolades and Recognition 

Dr. Pan has been recognized for her exemplary work through various academic and professional accomplishments. Her leadership in research projects—spanning university-level teaching reform, municipal innovation, and provincial management strategies—has cemented her reputation as a thought leader in her field.

🌍 Impact and Influence 

Community Impact

Dr. Pan’s work has had a profound impact on both academia and industry. By bridging the gap between theory and practice, her research offers actionable insights for businesses navigating the challenges of digital transformation. Her studies on digital supply chains and the value realization path of data as a factor of production have significantly influenced how organizations approach innovation and strategic management in the digital age.

🔮Legacy and Future Contributions 

Dr. Pan Xiaoyan’s legacy lies in her ability to address contemporary challenges in management through innovative research and practical applications. Moving forward, she is well-positioned to continue her contributions to the field, particularly in exploring the intersection of digital transformation, sustainability, and strategic innovation. Her research projects and publications serve as a valuable resource for academics, policymakers, and industry leaders alike.

Conclusion

Dr. Pan Xiaoyan’s unwavering commitment to advancing strategic management, innovation, and entrepreneurship makes her a leading figure in her discipline. Her academic rigor, professional achievements, and impactful research reflect her dedication to addressing the evolving challenges of the digital era. As a scholar, educator, and researcher, Dr. Pan exemplifies the qualities of a visionary leader, leaving an indelible mark on her field and paving the way for future advancements in management and digital transformation.

📚Publications

  • What Drives Firms to Go Green in China? The Role of Digitalization

    Authors: Pan, X., Xiao, S.

    Journals: Sustainability 

  • Strategic orientation, digital capabilities, and new product development in emerging market firms: The moderating role of corporate social responsibility

    Authors: Pan, X., Oh, K.-S., Wang, M.

    Journals:  Sustainability